Tag: immunotherapy
Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research
Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced a research collaboration agreement...
Juno Therapeutics’ and Celgene Corporation’s Investigational Drug JCAR017 Granted Breakthrough Therapy...
- Early results recently announced with JCAR017 in non-Hodgkin lymphoma and pediatric acute lymphoblastic leukemia
-- Pivotal DLBCL trial expected to begin in 2017
SEATTLE &...
